Regeneron Pharmaceuticals Stock Operating Margin

REGN Stock  USD 966.30  2.75  0.29%   
Regeneron Pharmaceuticals fundamentals help investors to digest information that contributes to Regeneron Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Regeneron Stock. The fundamental analysis module provides a way to measure Regeneron Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Regeneron Pharmaceuticals stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Regeneron Operating Margin Analysis

Regeneron Pharmaceuticals' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
 2021 2022 2023 2024 (projected)
Total Operating Expenses4.7B5.6B7.1B7.4B
Cost Of Revenue2.4B1.6B883.7M927.9M

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Regeneron Pharmaceuticals Operating Margin

    
  0.29 %  
Most of Regeneron Pharmaceuticals' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Regeneron Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Regeneron Operating Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for Regeneron Pharmaceuticals is extremely important. It helps to project a fair market value of Regeneron Stock properly, considering its historical fundamentals such as Operating Margin. Since Regeneron Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Regeneron Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Regeneron Pharmaceuticals' interrelated accounts and indicators.
1.0-0.060.990.980.32-0.660.970.980.830.940.980.580.930.580.430.870.290.950.761.00.960.990.650.88-0.910.760.610.9-0.67
1.0-0.090.990.960.28-0.670.950.970.850.960.960.550.940.560.380.850.270.940.741.00.940.990.640.87-0.90.770.620.9-0.69
-0.06-0.090.0-0.01-0.04-0.490.02-0.090.03-0.16-0.08-0.040.01-0.40.24-0.26-0.12-0.15-0.26-0.090.160.03-0.26-0.13-0.190.10.16-0.04-0.15
0.990.990.00.960.27-0.750.950.970.870.960.950.530.950.480.360.820.190.90.690.990.960.990.590.86-0.930.780.630.91-0.7
0.980.96-0.010.960.33-0.650.990.990.710.890.980.620.850.560.490.870.320.950.760.970.970.960.660.92-0.950.660.50.91-0.56
0.320.28-0.040.270.33-0.130.420.390.120.140.450.690.120.240.60.530.180.360.720.280.40.30.150.42-0.4-0.010.020.310.14
-0.66-0.67-0.49-0.75-0.65-0.13-0.63-0.65-0.71-0.66-0.61-0.25-0.710.11-0.19-0.390.26-0.46-0.24-0.67-0.75-0.73-0.15-0.590.81-0.58-0.48-0.730.57
0.970.950.020.950.990.42-0.630.970.710.860.990.680.840.610.590.890.340.960.820.960.980.960.690.88-0.940.670.540.87-0.57
0.980.97-0.090.970.990.39-0.650.970.750.910.980.610.850.530.440.890.270.930.790.980.960.960.630.94-0.940.630.460.94-0.53
0.830.850.030.870.710.12-0.710.710.750.870.720.280.940.370.130.540.130.70.440.840.750.870.40.59-0.710.810.690.72-0.79
0.940.96-0.160.960.890.14-0.660.860.910.870.870.360.940.470.160.760.190.840.620.960.850.930.540.82-0.820.770.580.89-0.7
0.980.96-0.080.950.980.45-0.610.990.980.720.870.730.840.590.540.910.290.960.840.970.960.960.670.9-0.920.660.540.88-0.55
0.580.55-0.040.530.620.69-0.250.680.610.280.360.730.410.490.720.680.240.670.740.560.620.560.510.56-0.570.320.390.43-0.23
0.930.940.010.950.850.12-0.710.840.850.940.940.840.410.470.240.70.180.830.570.940.860.950.520.69-0.790.90.790.79-0.85
0.580.56-0.40.480.560.240.110.610.530.370.470.590.490.470.50.630.60.770.70.560.470.530.90.4-0.340.450.390.32-0.33
0.430.380.240.360.490.6-0.190.590.440.130.160.540.720.240.50.620.280.580.660.380.560.430.540.34-0.490.220.330.24-0.12
0.870.85-0.260.820.870.53-0.390.890.890.540.760.910.680.70.630.620.280.90.920.860.850.820.640.81-0.770.530.470.75-0.41
0.290.27-0.120.190.320.180.260.340.270.130.190.290.240.180.60.280.280.420.350.260.230.250.320.25-0.170.250.120.18-0.04
0.950.94-0.150.90.950.36-0.460.960.930.70.840.960.670.830.770.580.90.420.850.940.90.920.810.81-0.830.690.570.78-0.57
0.760.74-0.260.690.760.72-0.240.820.790.440.620.840.740.570.70.660.920.350.850.750.750.710.660.72-0.670.420.370.62-0.29
1.01.0-0.090.990.970.28-0.670.960.980.840.960.970.560.940.560.380.860.260.940.750.950.990.640.87-0.90.770.620.9-0.68
0.960.940.160.960.970.4-0.750.980.960.750.850.960.620.860.470.560.850.230.90.750.950.970.590.86-0.970.70.580.88-0.61
0.990.990.030.990.960.3-0.730.960.960.870.930.960.560.950.530.430.820.250.920.710.990.970.620.84-0.930.780.650.89-0.71
0.650.64-0.260.590.660.15-0.150.690.630.40.540.670.510.520.90.540.640.320.810.660.640.590.620.52-0.50.470.370.46-0.34
0.880.87-0.130.860.920.42-0.590.880.940.590.820.90.560.690.40.340.810.250.810.720.870.860.840.52-0.910.480.210.97-0.26
-0.91-0.9-0.19-0.93-0.95-0.40.81-0.94-0.94-0.71-0.82-0.92-0.57-0.79-0.34-0.49-0.77-0.17-0.83-0.67-0.9-0.97-0.93-0.5-0.91-0.58-0.41-0.930.48
0.760.770.10.780.66-0.01-0.580.670.630.810.770.660.320.90.450.220.530.250.690.420.770.70.780.470.48-0.580.890.58-0.81
0.610.620.160.630.50.02-0.480.540.460.690.580.540.390.790.390.330.470.120.570.370.620.580.650.370.21-0.410.890.31-0.9
0.90.9-0.040.910.910.31-0.730.870.940.720.890.880.430.790.320.240.750.180.780.620.90.880.890.460.97-0.930.580.31-0.4
-0.67-0.69-0.15-0.7-0.560.140.57-0.57-0.53-0.79-0.7-0.55-0.23-0.85-0.33-0.12-0.41-0.04-0.57-0.29-0.68-0.61-0.71-0.34-0.260.48-0.81-0.9-0.4
Click cells to compare fundamentals
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Regeneron Pretax Profit Margin

Pretax Profit Margin

0.32

At this time, Regeneron Pharmaceuticals' Pretax Profit Margin is very stable compared to the past year.
Based on the recorded statements, Regeneron Pharmaceuticals has an Operating Margin of 0.292%. This is 100.83% lower than that of the Biotechnology sector and 100.26% lower than that of the Health Care industry. The operating margin for all United States stocks is 105.3% lower than that of the firm.

Regeneron Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Regeneron Pharmaceuticals' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Regeneron Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Regeneron Pharmaceuticals by comparing valuation metrics of similar companies.
Regeneron Pharmaceuticals is currently under evaluation in operating margin category among related companies.

Regeneron Pharmaceuticals ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Regeneron Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Regeneron Pharmaceuticals' managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Regeneron Fundamentals

About Regeneron Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Regeneron Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Regeneron Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Regeneron Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company was incorporated in 1988 and is headquartered in Tarrytown, New York. Regeneron Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 10915 people.

Regeneron Pharmaceuticals Investors Sentiment

The influence of Regeneron Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Regeneron. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Regeneron Pharmaceuticals' public news can be used to forecast risks associated with an investment in Regeneron. The trend in average sentiment can be used to explain how an investor holding Regeneron can time the market purely based on public headlines and social activities around Regeneron Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Regeneron Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Regeneron Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Regeneron Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Regeneron Pharmaceuticals.

Regeneron Pharmaceuticals Implied Volatility

    
  25.45  
Regeneron Pharmaceuticals' implied volatility exposes the market's sentiment of Regeneron Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Regeneron Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Regeneron Pharmaceuticals stock will not fluctuate a lot when Regeneron Pharmaceuticals' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Regeneron Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Regeneron Pharmaceuticals' short interest history, or implied volatility extrapolated from Regeneron Pharmaceuticals options trading.

Currently Active Assets on Macroaxis

When determining whether Regeneron Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regeneron Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regeneron Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regeneron Pharmaceuticals Stock:
Check out Regeneron Pharmaceuticals Piotroski F Score and Regeneron Pharmaceuticals Altman Z Score analysis.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.
Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Regeneron Stock analysis

When running Regeneron Pharmaceuticals' price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Is Regeneron Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.03)
Earnings Share
34.78
Revenue Per Share
122.935
Quarterly Revenue Growth
0.006
Return On Assets
0.0849
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.